rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jeffrey D. Marrazzo

Director

Company insider

Files Form 4 as: Director, Prime Medicine; Chief Executive Officer, Spark Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
125
Buys
0
Sells
23
Bought
$0
Sold
$20.0M
Companies
2
Companies where not an officer
1
First trade
16 Mar 2015
Last trade
5 Jun 2026
Last filed
8 Jun 2026

Companies traded

Where they are an officer
Spark TherapeuticsDirector, Officer · last 17 Dec 20190 buys · 23 sells
Everywhere else they filed: board seats, 10% stakes, other companies
PRME Prime MedicineDirector · Biotechnology · last 5 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 8 Jun 2026PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
5 Jun 2026filed 8 Jun 2026PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code D—92,000filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—92,000filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code D—250,000filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—250,000filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code D—45,000filing
1 Aug 2025filed 5 Aug 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—45,000filing
4 Jun 2025filed 5 Jun 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
19 May 2025filed 19 May 2025PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—800,000 at $0.00filing
12 Jun 2024filed 14 Jun 2024PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
29 Feb 2024filed 4 Mar 2024PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—250,000 at $0.00filing
10 May 2023filed 12 May 2023PRME Prime Medicineoption or derivative · BiotechnologySEC FORM 4 Code A—92,000 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—98,000 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—52,500 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—70,000 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—135,000 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—125,000 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—126,131 at $0.00filing
17 Dec 2019filed 17 Dec 2019Spark Therapeuticsoption or derivativeSEC FORM 4 Code D—49,250 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed23

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.